Drug or treatment

Inebilizumab clinical trials

• 8Clinical trials
• 19Countries

Newest trials

All recruiting trials (8)

• Inebilizumab for Type 1 Autoimmune Pancreatitis in Adults

  This study tests whether inebilizumab can help adults with type 1 autoimmune pancreatitis by reducing relapses when paired with a standardized steroid taper.

  Recruiting Phase 4 Ruijin Hospital · Shanghai · NCT07862075

• Inebilizumab for primary membranous nephropathy in adults

  This study tests whether inebilizumab can help achieve complete remission in adults with primary membranous nephropathy who have significant protein in the urine.

  Recruiting at 4 sites Phase 3 Amgen · Los Angeles, California and 3 other locations · NCT07851220

• Inebilizumab for Autoimmune Hepatitis: a study in adults

  This trial tests whether inebilizumab can be safely used in adults with autoimmune hepatitis and whether it helps reduce liver disease activity and the need for steroids.

  Recruiting at 35 sites Phase 3 Amgen · Little Rock, Arkansas and 35 other locations · NCT07598825

• Rituximab vs multiple approved NMOSD therapies to prevent relapses

  This study tests whether rituximab or one of four other approved medicines is better at preventing NMOSD relapses in adults who have AQP4-IgG.

  Recruiting at 2 sites Phase 4 Massachusetts General Hospital · Boston, Massachusetts and 2 other locations · NCT07010302

• Inebilizumab in children with generalized myasthenia gravis: drug handling and tolerability

  This trial will test inebilizumab in children aged 2 to 17 with generalized myasthenia gravis to see how the drug is processed in the body and whether it is safe and well tolerated.

  Recruiting at 14 sites Phase 2 Amgen · Chicago, Illinois and 13 other locations · NCT06987539

• Testing inebilizumab and subcutaneous blinatumomab in adults with active, treatment‑resistant lupus or refractory rheumatoid arthritis

  This trial tests inebilizumab for adults with active, treatment‑resistant lupus with nephritis and tests subcutaneous blinatumomab for adults with active, treatment‑resistant lupus (with or without nephritis) and for adults with active refractory rheumatoid arthritis.

  Recruiting at 48 sites Phase 2 Amgen · Scottsdale, Arizona and 57 other locations · NCT06570798

• Evaluating Inebilizumab for Children with Neuromyelitis Optica Spectrum Disorder

  This study is testing a new treatment called inebilizumab to see if it can help children with a specific type of neuromyelitis optica spectrum disorder feel better and stay safe during the treatment.

  Recruiting at 19 sites Phase 2 Amgen · La Jolla, California and 18 other locations · NCT05549258

• Investigating Inebilizumab for NMDAR Encephalitis

  This study is testing if a new treatment called inebilizumab can help people with NMDAR encephalitis recover better than standard therapies or a placebo.

  Recruiting at 39 sites Phase 2 University of Utah · Birmingham, Alabama and 38 other locations · NCT04372615

Quick answers

How many clinical trials of Inebilizumab are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 19 countries. The most sites are in United States (7 trials), France (4 trials), Spain (4 trials), Germany (3 trials), Italy (3 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 2, Phase 4: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →